title: Characterization and regulation of peptidylglycine alpha-amidating monooxygenase (PAM) expression in H9c2 cardiac myoblasts.
abstract: Peptidylglycine alpha-amidating monooxygenase (PAM), which catalazyes the two-step formation of bioactive alpha-amidated peptides from their glycine-extended precursors, has been found in H9c2 myoblasts. The expression of PAM has been evaluated in H9c2 cells. Northern blot analysis and amplification of fragments derived from rat PAM by the reverse transcription/polymerase chain reaction method has demonstrated the presence of rPAM-1, -2, -3, -3a and -3b mRNA transcripts. These forms of PAM mRNA may be generated by alternative splicing. PAM mRNA levels are increased to 160 +/- 12% of control values by treatment with dexamethasone but are unchanged during triiodothyronine incubation of the cells. PAM activity is very low, which is not comparable to the high levels found in adult atrium tissue. Western blot analysis has demonstrated 86-, 76-, and 46-kDa PAM proteins in the particulate fraction. The soluble fraction contains major PAM proteins of 110, 86, and 46 kDa. In situ hybridization studies with 35S-labeled full length RNA antisense transcripts of rat PAM-1 cDNA have localized autoradiographic grains around the nucleus. Our data clearly demonstrate PAM expression in H9c2 rat heart cells, suggesting the ability of these cardiac cells to make bioactive alpha-amidated hormones and/or neuropeptides.
authors.affiliation: Laboratoire de Cancérologie Expérimentale, EA 2671, Université de la Méditérranée, IFR Jean Roche, Faculté de médecine Nord, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Girard
authors.forename: L
authors.initials: L
authors.lastname: Ouafik
authors.forename: F
authors.initials: F
authors.lastname: Boudouresque
mesh_terms: D017398:Alternative Splicing / Q000502:physiology; D000818:Animals; D015153:Blotting, Western; D002999:Clone Cells; D003907:Dexamethasone / Q000494:pharmacology; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects; D005938:Glucocorticoids / Q000494:pharmacology; D017403:In Situ Hybridization; D006899:Mixed Function Oxygenases / Q000032:analysis / Q000235:genetics* / Q000378:metabolism*; D009097:Multienzyme Complexes; D018485:Muscle Fibers, Skeletal / Q000201:enzymology*; D009206:Myocardium / Q000166:cytology* / Q000201:enzymology; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D014284:Triiodothyronine / Q000494:pharmacology
chemical_list: D005938:Glucocorticoids; D009097:Multienzyme Complexes; D012333:RNA, Messenger; D014284:Triiodothyronine; D003907:Dexamethasone; D006899:Mixed Function Oxygenases; C035189:peptidylglycine monooxygenase